Other interstitial pulmonary diseases
Notes: Essential brown induration of lung ; Capillary fibrosis of lung ; Cirrhosis of lung (chronic) NOS ; Fibrosis of lung (atrophic) (chronic) (confluent) (massive) (perialveolar) (peribronchial) NOS ; Induration of lung (chronic) NOS ; Postinflammatory pulmonary fibrosis ; Cryptogenic fibrosing alveolitis ; Idiopathic fibrosing alveolitis ; Hamman-Rich syndrome ; Progressive fibrotic interstitial lung disease ; Interstitial pneumonia (nonspecific) (usual) due to collagen vascular disease ; Interstitial pneumonia (nonspecific) (usual) in diseases classified elsewhere ; Organizing pneumonia due to collagen vascular disease ; Organizing pneumonia in diseases classified elsewhere ; Lymphoid interstitial pneumonitis ; Lymphangiomyomatosis ; Adult PLCH ; Endogenous lipoid pneumonia ; Interstitial pneumonitis ; Non-specific interstitial pneumonitis NOS ; Organizing pneumonia NOS ; Interstitial pneumonia NOS ; code, for adverse effect, to identify drug (T36-T50 with fifth or sixth character 5), if drug-induced ; drug-induced interstitial lung disorders (J70.2-J70.4) ; interstitial emphysema (J98.2) ; acute idiopathic pulmonary hemorrhage in infants [AIPHI] (R04.81) ; pulmonary fibrosis (chronic) due to inhalation of chemicals, gases, fumes or vapors (J68.4) ; pulmonary fibrosis (chronic) following radiation (J70.1) ; lymphoid interstitial pneumonia (J84.2) ; pneumocystis pneumonia (B59) ; non-specific interstitial pneumonia NOS, or due to known underlying cause (J84.89) ; pneumocystis pneumonia (B59) ; organizing pneumonia NOS, or due to known underlying cause (J84.89) ; exogenous lipoid pneumonia (J69.1) ; unspecified lipoid pneumonia (J69.1) ; cryptogenic organizing pneumonia (J84.116) ; idiopathic non-specific interstitial pneumonitis (J84.113) ; lipoid pneumonia, exogenous or unspecified (J69.1) ; lymphoid interstitial pneumonia (J84.2) ; lung diseases due to external agents (J60-J70) ; underlying disease, such as: ; disorders of iron metabolism (E83.1-) ; underlying disease, such as: ; lung diseases due to external agents (J60-J70) ; rheumatoid arthritis (M05.00-M06.9) ; sarcoidosis (D86) ; systemic connective tissue disorders (M30-M36) ; underlying disease, such as: ; progressive systemic sclerosis (M34.0) ; rheumatoid arthritis (M05.00-M06.9) ; systemic lupus erythematosis (M32.0-M32.9) ; , if applicable: ; poisoning due to drug or toxin (T51-T65 with fifth or sixth character to indicate intent), for toxic pneumonopathy ; underlying cause of pneumonopathy, if known